End-tagging of ultra-short antimicrobial peptides by W/F stretches to facilitate bacterial killing

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Pasupuleti, Mukesh ^a   Schmidtchen, Artur ^a   Chalupka, Anna ^a   Ringstad, Lovisa ^b   Malmsten, Martin ^b  

^a LUND UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTERIUM LIPOPOLYSACCHARIDE; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; ELASTASE; KININOGEN; LIPOSOME; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEINASE; SODIUM CHLORIDE; ANTIINFECTIVE AGENT; PEPTIDE;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERICIDAL ACTIVITY; BINDING KINETICS; CELL PERMEABILIZATION; CONTROLLED STUDY; DRUG POTENCY; DRUG STABILITY; ESCHERICHIA COLI; EUKARYOTIC CELL; EX VIVO STUDY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; IONIC STRENGTH; NONHUMAN; PEPTIDE SYNTHESIS; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; SWINE; AMINO ACID SEQUENCE; BIOAVAILABILITY; CELL LINE; CHEMISTRY; DRUG EFFECT; HUMAN; MICROBIOLOGICAL EXAMINATION; MOLECULAR GENETICS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; EUKARYOTA; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS; SUIDAE;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BIOLOGICAL AVAILABILITY; CELL LINE; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PEPTIDES; STAPHYLOCOCCUS AUREUS;

EID: 65449153221     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005285     Document Type: Article

References (57)

1. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.
2. Marr AK, Gooderham WJ, Hancock RE (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 6: 468-472.
3. Toke O (2005) Antimicrobial peptides: new candidates in the fight against bacterial infections. Biopolymers 80: 717-735.
4. Nizet V (2006) Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr Issues Mol Biol 8: 11-26.
5. Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3: 238-250.
6. Huang HW (2006) Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim Biophys Acta 1758: 1292-1302.
7. Hancock RE, Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24: 1551-1557.
8. Zelezetsky I, Tossi A (2006) Alpha-helical antimicrobial peptides-using a sequence template to guide structure-activity relationship studies. Biochim Biophys Acta 1758: 1436-1449.
9. Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, et al. (2005) Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J Biol Chem 280: 12316-12329.
10. Taboureau O, Olsen OH, Nielsen JD, Raventos D, Mygind PH, et al. (2006) Design of novispirin antimicrobial peptides by quantitative structure-activity relationship. Chem Biol Drug Des 68: 48-57.
11. Jenssen H, Lejon T, Hilpert K, Fjell CD, Cherkasov A, et al. (2007) Evaluating different descriptors for model design of antimicrobial peptides with enhanced activity toward P. aeruginosa. Chem Biol Drug Des 70: 134-142.
12. Pasupuleti M, Walse B, Svensson B, Malmsten M, Schmidtchen A (2008) Rational design of antimicrobial C3a analogues with enhanced effects against Staphylococci using an integrated structure and function-based approach. Biochemistry 47: 9057-9070.
13. Nell MJ, Tjabringa GS, Wafelman AR, Verrijk R, Hiemstra PS, et al. (2006) Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application. Peptides 27: 649-660.
14. Nordahl EA, Rydengård V, Nyberg P, Nitsche DP, Mörgelin M, et al. (2004) Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A 101: 16879-16884.
15. Sonesson A, Ringstad L, Andersson Nordahl E, Malmsten M, Morgelin M, et al. (2006) Antifungal activity of C3a and C3a-derived peptides against Candida. Biochim Biophys Acta 1768: 346-353.
16. Pasupuleti M, Walse B, Nordahl EA, Morgelin M, Malmsten M, et al. (2007) Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans. J Biol Chem 282: 2520-2528.
17. Nordahl EA, Rydengård V, Mörgelin M, Schmidtchen A (2005) Domain 5 of high molecular weight kininogen is antibacterial. J Biol Chem 280: 34832-34839.
18. Malmsten M, Davoudi M, Walse B, Rydengard V, Pasupuleti M, et al. (2007) Antimicrobial peptides derived from growth factors. Growth Factors 25: 60-70.
19. Malmsten M, Davoudi M, Schmidtchen A (2006) Bacterial killing by heparin-binding peptides from PRELP and thrombospondin. Matrix Biol 25: 294-300.
20. Ringstad L, Schmidtchen A, Malmsten M (2006) Effect of Peptide Length on the Interaction between Consensus Peptides and DOPC/DOPA Bilayers. Langmuir 22: 5042-5050.
21. Tossi A, Sandri L, Giangaspero A (2000) Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55: 4-30.
22. Jerala R (2007) Synthetic lipopeptides: a novel class of anti-infectives. Expert Opin Investig Drugs 16: 1159-1169.
23. Straus SK, Hancock RE (2006) Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Biochim Biophys Acta 1758: 1215-1223.
24. Makovitzki A, Shai Y (2005) pH-dependent antifungal lipopeptides and their plausible mode of action. Biochemistry 44: 9775-9784.
25. Avrahami D, Shai Y (2002) Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity. Biochemistry 41: 2254-2263.
26. Avrahami D, Shai Y (2003) Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acid-containing antimicrobial peptides: a plausible mode of action. Biochemistry 42: 14946-14956.
27. Avrahami D, Shai Y (2004) A new group of antifungal and antibacterial lipopeptides derived from non-membrane active peptides conjugated to palmitic acid. J Biol Chem 279: 12277-12285.
28. Schmidtchen A, Pasipuleti M, Mörgelin M, Davoudi M, Alenfall J, et al. (2008) Boosting antimicrobial peptides by hydrophobic amino acid end-tags. J Biol Chem.
29. Lee V, ed (1991) Peptide and protein drug delivery. New York: Marcel Dekker.
30. Lehrer RI, Rosenman M, Harwig SS, Jackson R, Eisenhauer P (1991) Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods 137: 167-173.
31. Andersson E, Rydengård V, Sonesson A, Mörgelin M, Björck L, et al. (2004) Antimicrobial activities of heparin-binding peptides. Eur J Biochem 271: 1219-1226.
32. Ulevitch RJ (1978) The preparation and characterization of a radioiodinated bacterial lipopolysaccharide. Immunochemistry 15: 157-164.
33. Cheng F, Yoshida K, Heinegard D, Fransson LA (1992) A new method for sequence analysis of glycosaminoglycans from heavily substituted proteoglycans reveals non-random positioning of 4- and 6-O-sulphated N-acetylgalactosamine in aggrecan-derived chondroitin sulphate. Glycobiology 2: 553-561.
34. McDonnell G, Haines K, Klein D, Rippon M, Walmsley R, et al. (1999) Clinical correlation of a skin antisepsis model. J Microbiol Methods 35: 31-35.
35. Schmidtchen A, Frick IM, Andersson E, Tapper H, Bjorck L (2002) Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol 46: 157-168.
36. Bernard P (2008) Management of common bacterial infections of the skin. Curr Opin Infect Dis 21: 122-128.
37. Tourmousoglou CE, Yiannakopoulou EC, Kalapothaki V, Bramis J, St Papadopoulos J (2008) Surgical-site infection surveillance in general surgery: a critical issue. J Chemother 20: 312-318.
38. Ramamoorthy A, Thennarasu S, Lee DK, Tan A, Maloy L (2006) Solid-state NMR investigation of the membrane-disrupting mechanism of antimicrobial peptides MSI-78 and MSI-594 derived from magainin 2 and melittin. Biophys J 91: 206-216.
39. Ringstad L, Andersson Nordahl E, Schmidtchen A, Malmsten M (2007) Composition Effect on Peptide Interaction with Lipids and Bacteria: Variants of C3a Peptide CNY21. Biophys J 92: 87-98.
40. Ringstad L, Kacprzyk L, Schmidtchen A, Malmsten M (2007) Effects of topology, length, and charge on the activity of a kininogen-derived peptide on lipid membranes and bacteria. Biochim Biophys Acta 1768: 715-727.
41. Ringstad L, Protopapa E, Lindholm-Sethson B, Schmidtchen A, Nelson A, et al. (2008) An electrochemical study into the interaction between complement-derived peptides and DOPC mono- and bilayers. Langmuir 24: 208-216.
42. Chen FY, Lee MT, Huang HW (2003) Evidence for membrane thinning effect as the mechanism for peptide-induced pore formation. Biophys J 84: 3751-3758.
43. Javadpour MM, Juban MM, Lo WC, Bishop SM, Alberty JB, et al. (1996) De novo antimicrobial peptides with low mammalian cell toxicity. J Med Chem 39: 3107-3113.
44. Malmsten M, Veide A (1996) Effects of amino acid composition on protein adsorption. Journal of colloid and interface science 178: 160-167.
45. Malmsten M, Burns N, Veide A (1998) Electrostatic and Hydrophobic Effects of Oligopeptide Insertions on Protein Adsorption. J Colloid Interface Sci 204: 104-111.
46. Chan DI, Prenner EJ, Vogel HJ (2006) Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim Biophys Acta 1758: 1184-1202.
47. Petersen FN, Jensen MO, Nielsen CH (2005) Interfacial tryptophan residues: a role for the cation-pi effect? Biophys J 89: 3985-3996.
48. Glukhov E, Stark M, Burrows LL, Deber CM (2005) Basis for selectivity of cationic antimicrobial peptides for bacterial versus mammalian membranes. J Biol Chem 280: 33960-33967.
49. Li X, Li Y, Peterkofsky A, Wang G (2006) NMR studies of aurein 1.2 analogs. Biochim Biophys Acta 1758: 1203-1214.
50. Haney EF, Lau F, Vogel HJ (2007) Solution structures and model membrane interactions of lactoferrampin, an antimicrobial peptide derived from bovine lactoferrin. Biochim Biophys Acta 1768: 2355-2364.
51. McInturff JE, Wang SJ, Machleidt T, Lin TR, Oren A, et al. (2005) Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes. J Invest Dermatol 125: 256-263.
52. Deslouches B, Phadke SM, Lazarevic V, Cascio M, Islam K, et al. (2005) De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrob Agents Chemother 49: 316-322.
53. Lorenz D, Wiesner B, Zipper J, Winkler A, Krause E, et al. (1998) Mechanism of peptide-induced mast cell degranulation. Translocation and patch-clamp studies. J Gen Physiol 112: 577-591.
54. Makovitzki A, Baram J, Shai Y (2008) Antimicrobial lipopolypeptides composed of palmitoyl Di- and tricationic peptides: in vitro and in vivo activities, self-assembly to nanostructures, and a plausible mode of action. Biochemistry 47: 10630-10636.
55. Costa MC, Rolemberg MP, Boros LAD, Krähenbühl MA, De Oliveira MG, et al. (2007) Solid-Liquid Equilibrium of Binary Fatty Acid Mixtures. Journal of Chemical & Engineering Data 52: 30-36.
56. Ember JA, Johansen NL, Hugli TE (1991) Designing synthetic superagonists of C3a anaphylatoxin. Biochemistry 30: 3603-3612.
57. Del Rio G, Castro-Obregon S, Rao R, Ellerby HM, Bredesen DE (2001) APAP, a sequence-pattern recognition approach identifies substance P as a potential apoptotic peptide. FEBS Lett 494: 213-219.